全文获取类型
收费全文 | 4497篇 |
免费 | 274篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 48篇 |
儿科学 | 74篇 |
妇产科学 | 74篇 |
基础医学 | 719篇 |
口腔科学 | 180篇 |
临床医学 | 405篇 |
内科学 | 1046篇 |
皮肤病学 | 118篇 |
神经病学 | 366篇 |
特种医学 | 177篇 |
外科学 | 621篇 |
综合类 | 23篇 |
一般理论 | 1篇 |
预防医学 | 230篇 |
眼科学 | 49篇 |
药学 | 314篇 |
中国医学 | 5篇 |
肿瘤学 | 342篇 |
出版年
2023年 | 31篇 |
2022年 | 69篇 |
2021年 | 91篇 |
2020年 | 78篇 |
2019年 | 88篇 |
2018年 | 96篇 |
2017年 | 72篇 |
2016年 | 88篇 |
2015年 | 117篇 |
2014年 | 143篇 |
2013年 | 199篇 |
2012年 | 326篇 |
2011年 | 335篇 |
2010年 | 194篇 |
2009年 | 189篇 |
2008年 | 267篇 |
2007年 | 284篇 |
2006年 | 299篇 |
2005年 | 282篇 |
2004年 | 241篇 |
2003年 | 239篇 |
2002年 | 199篇 |
2001年 | 71篇 |
2000年 | 37篇 |
1999年 | 69篇 |
1998年 | 53篇 |
1997年 | 43篇 |
1996年 | 39篇 |
1995年 | 29篇 |
1994年 | 23篇 |
1993年 | 34篇 |
1992年 | 48篇 |
1991年 | 39篇 |
1990年 | 20篇 |
1989年 | 16篇 |
1988年 | 23篇 |
1987年 | 30篇 |
1986年 | 23篇 |
1985年 | 30篇 |
1984年 | 20篇 |
1983年 | 15篇 |
1982年 | 16篇 |
1981年 | 14篇 |
1979年 | 15篇 |
1978年 | 10篇 |
1976年 | 9篇 |
1975年 | 9篇 |
1974年 | 12篇 |
1973年 | 10篇 |
1970年 | 9篇 |
排序方式: 共有4792条查询结果,搜索用时 421 毫秒
1.
2.
Torsten T. Bauer Joachim Lorenz Klaus-Friedrich Bodmann Friedrich Vogel 《Medizinische Klinik》2005,26(13):355-360
Hintergrund:
Die nosokomiale Pneumonie gehört zu den häufigsten nosokomialen Infektionen und ist die häufigste auf der Intensivstation. Die nosokomiale Pneumonie ist mit einer signifikanten Mortalität und Morbidität assoziiert, und ihr Auftreten verschlechtert die Prognose des Patienten deutlich. Nach der Definition der DRGs auch im deutschen Krankenhaussystem ist die nosokomiale Pneumonie überwiegend Sache des Krankenhauses und kann somit nicht nur das Ergebnis der Patientenbehandlung, sondern auch das finanzielle Ergebnis des Krankenhauses beeinträchtigen. 相似文献3.
Dimmeler Stefanie; Tonn Torsten; Seeger Florian; Zeiher Andreas M. 《European heart journal》2007,28(17):2175
It obviously escaped the notion of Egeland and Brinchman thatthe protocols additionally differ with regard to the washingsteps and buffer components used in the 相似文献
4.
5.
Hans Rommelspacher Lutz G. Schmidt Torsten May 《Alcoholism, clinical and experimental research》1991,15(3):553-559
Based on the hypothesis that condensation products of neurotransmitters with aldehydes are involved in the pathogenesis of alcoholism, aromatic beta-carbolines (norharman and harman) were measured in the blood plasma of alcoholics and nonalcoholics. The identity of the extracted compounds was confirmed by various elution conditions of the high performance liquid chromatography (HPLC), newly developed radioreceptor assays, and the mass spectrum of norharman. The levels of norharman and harman in nonalcoholics were unchanged after a load with ethanol (1 g/kg body weight). The norharman levels of the alcoholics were significantly higher than that of the nonalcoholic controls (99.5 +/- 26.6 pg/ml vs. 26.9 +/- 10.7 pg/ml; p less than 0.001) and did not change significantly during a 3-week detoxication period. In the subgroup of alcoholics with delirium or hallucinosis, a slight increase of norharman during detoxication could be detected while in alcoholics with vegetative withdrawal symptoms norharman levels dropped slightly over time (p = 0.07). No difference was found with respect to harman between nonalcoholics and alcoholics. These results suggest disturbed regulatory processes in the formation and/or metabolism of norharman in alcoholics. Further investigations are needed to reveal a possible marker function of norharman in alcoholic patients. 相似文献
6.
J P van Wouwe M C Wijnands P E Mourad-Baars J P Geraedts G C Beverstock J J van de Kamp 《American journal of medical genetics》1986,24(2):211-217
We report on a severely retarded girl with multiple congenital anomalies. Chromosome studies showed a der (8) chromosome with dup(10p) and deficiency for a small distal segment of 8q. Her father proved to be carrier of a de novo balanced translocation between chromosome 8q and 10p. At 1 year the patient was also found to have the Pendred syndrome, an autosomal recessive defect in thyroid organification. The concurrence of chromosome anomalies and single gene disorders might not be too rare, but can be easily overlooked. Yet there are important consequences for genetic counseling. Moreover, recognition of these concurrences may help gene mapping. 相似文献
7.
H Pijl H P Koppeschaar F L Willekens I Op de Kamp H D Veldhuis A E Meinders 《International journal of obesity (2005)》1991,15(3):237-242
The effect of fluoxetine on body weight and spontaneous food choice was studied in twenty-three healthy, non-depressed, obese females on an outpatient basis. After a one week placebo run-in period, subjects were randomized to receive either fluoxetine (FXT) 60 mg daily (n = 11) or placebo (P) (n = 12) for 6 weeks in a double blind study design. BMI (35.2 +/- 0.8 vs 36.4 +/- 1.3 kg/m2, mean +/- s.e.m.) and age (38.1 +/- 239 vs 37.3 +/- 2.7 years) were not different in either group. No specific diet was prescribed. On four separate days per 14 days food records were collected. Data were analysed with the use of food composition tables. Statistical analysis was performed using Student's t test for independent samples for data on body weight and calorie intake. Macro-nutrient composition of the diet was analysed using multivariate analysis of variance and post hoc Student's t test for independent samples. All subjects lost weight during fluoxetine treatment. Mean (+/- s.e.m.) weight loss in the fluoxetine treated group was 3.6 +/- 0.5 kg, compared to a mean weight gain of 0.3 +/- 0.5 kg in the placebo treated group (P less than 0.001). In all patients food intake was reduced during fluoxetine treatment and this reduction could fully account for the observed weight loss. The mean total caloric intake per day was significantly lower during fluoxetine treatment compared with placebo (FXT 1123 +/- 118 kcal vs P 1845 +/- 87 kcal, P less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
8.
9.
Plasma level Studies on Volunteers after Intramuscular Application of Different Doses of Etofenamate in Oily Solution. After i.m. injections of etofenamate (active substance of Rheumon i.m.) in oily solution to 12 volunteers, courses of plasma levels of etofenamate, flufenamic acid and fenamate (sum of etofenamate and flufenamic acid) were measured by HPTLC. Maximum levels of etofenamate, flufenamic acid and fenamate, as well as areas under the plasma level time curve (AUC) after 250, 500 and 1000 mg etofenamate respectively are proportional to dose. Maxima of fenamate plasma levels are reached after 6.3, 6.2 and 5.4 h respectively, half maximal levels are present already after 2 h. The mean residence time is 21.8, 18.8 and 15.7 h. These values obtained from different doses are not statistically different from each other. Pharmacokinetics are therefore linear and dose independent. The courses of fenamate levels can be described by a two compartment model. The elimination half lives after 250, 500 and 1000 mg are 2.1, 2.3 and 1.9 h, the invasion half-lives (dominant half-life) 8.8, 7.8 and 6.8 h. Terminal half-lives are 50.3, 63.7 and 35.4 h. Since plasma levels have decreased to 2% of the maximum level after one terminal half-life, they have no practical importance for the duration of activity or for accumulation. No sex related differences are found for dose dependent and independent parameters. From the data it can be derived that after i.m. injection of etofenamate in oily solution a prolongation of the dominant half-life occurs by a factor of 4-5 (as compared to oral data) which is caused by prolonged liberation from the oily depot. This long lasting liberation of etofenamate leads to a prolonged residence time after a fast increase, at the same time avoiding unnecessary high peak levels. Therefore it is guaranteed that even after i.m. administration of 1000 mg etofenamate in oily solution plasma levels of fenamate do not exceed those after 300 mg given orally. According to pharmacokinetic data a fast onset of action, good tolerability and a therapeutic action over a period of 24 h can be expected. 相似文献
10.
Clinical follow-up of 193-nm ArF excimer laser photokeratectomy. 总被引:9,自引:0,他引:9
The excimer laser has been undergoing rapid development for clinical use since the early 1980s. The authors report 2-year follow-up results from studies in 31 eyes (15 women and 14 men) to evaluate the excimer laser in performing photokeratectomy. Patients were divided into two groups: 27 eyes (group 1) underwent phototherapeutic keratectomy, and 4 eyes (group 2) underwent photorefractive keratectomy. Visual function improved in 21 of 27 eyes in group 1 and in 2 of 4 eyes in group 2. Complications were minimal and manageable. The authors describe a procedure to minimize induced hyperopia in phototherapeutic keratectomy patients, and, although not statistically significant, less induced hyperopia was noted in these patients. Photokeratectomy may be an alternative to penetrating or lamellar keratoplasty and more invasive refractive procedures, but the long-term effects must be carefully observed. 相似文献